Last Updated: Wednesday, September 12, 2012, 20:49
The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.
Last Updated: Tuesday, September 11, 2012, 21:00
The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.
more videos >>
